Eli Lilly and Company and Ventyx Biosciences, Inc. , a San Diego-based clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatory-mediated diseases, announced entry into a definitive agreement for Lilly to acquire Ventyx. Ventyx is developing a pipeline of…
Helix, the leading enterprise genomics company, announced a multi-year strategic collaboration with GSK, the global biopharma company. This agreement provides GSK access to Helix's continuously growing, deeply phenotyped GenoSphere™ cohorts that cover a wide range of disease areas. Helix GenoSphere™ cohorts consist o…
SOPHiA GENETICS, a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center announced a strategic collaboration that unites SOPHiA GENETICS' AI-powered analytics with MD Anderson's clinical and scientific expertise to accelerate data-driven cancer care through new tools tha…
Amgen announced its acquisition of Dark Blue Therapeutics Ltd., a privately held biotechnology company based in the United Kingdom advancing first-in-class, small molecule-targeted protein degraders for oncology, in a transaction valued at up to $840 million. The acquisition adds to Amgen's portfolio an investigati…
Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, announced a strategic collaboration with Sanofi to apply Earendil's discovery platform to multiple autoimmune and inflammatory disease programs. Sanofi will lead the development and worldwide commercializati…
Intelligent Bio Solutions Inc., a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced a new strategic manufacturing partnership with Syrma Johari MedTech Ltd. (“Syrma Johari”), a globally recognized medical device engineering and manufacturing organization with over 45 y…
Insilico Medicine, a world-leading artificial intelligence (AI)-driven drug discovery company, announced a multi-year research and development (R&D) collaboration with Servier, an independent international pharmaceutical company governed by a foundation. This strategic alliance is focused on identifying and develo…
Brenntag, the global leader in chemicals and ingredients distribution, has signed an exclusive distribution agreement with Henan Yongchang Nitro Fertilizer Co., Ltd. for nitric acid, covering the markets of Australia and New Zealand. Henan Yongchang is a long-established chemical producer based in Huixian City in …
Transcenta Holding Limited, a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announced it has entered into a strategic collaboration and non-exclusive licensing agreement with EirGenix Inc., a glob…
ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity investment from Eli Lilly and Company ("Lilly"). ABL Bio and Li…
Page 26 of 43